Parexel International Corp., a Waltham biotechnology services company, said Thursday that it has purchased the software maker Liquent Inc. for $72 million.

Liquent, based in Horsham, Pa., makes software used by drug companies to manage regulatory submissions and product registrations. The purchase of Liquent will allow Parexel to expand the consulting services it provides to biotech and medical device companies.